Fairman Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24K | Hold |
500
| – | – | ﹤0.01% | 218 |
|
|
2025
Q1 | $1.46K | Hold |
500
| – | – | ﹤0.01% | 210 |
|
|
2024
Q4 | $1.46K | Hold |
500
| – | – | ﹤0.01% | 239 |
|
|
2024
Q3 | $1.94K | Hold |
500
| – | – | ﹤0.01% | 279 |
|
|
2024
Q2 | $2.57K | Hold |
500
| – | – | ﹤0.01% | 246 |
|
|
2024
Q1 | $3.5K | Hold |
500
| – | – | ﹤0.01% | 213 |
|
|
2023
Q4 | $4.43K | Buy |
+500
| New | +$4.43K | ﹤0.01% | 200 |
|